Barclays Maintains Overweight on Sempra, Raises Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont maintains an Overweight rating on Sempra (NYSE:SRE) and raises the price target from $81 to $87.
August 13, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Eric Beaumont maintains an Overweight rating on Sempra and raises the price target from $81 to $87.
The Overweight rating and increased price target from a reputable analyst at Barclays is likely to positively influence investor sentiment and drive short-term price appreciation for Sempra.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100